Literature DB >> 12875523

Biotypes and antimicrobial susceptibilities of Brucella isolates.

Hürrem Bodur1, Neriman Balaban, Sebahat Aksaray, Vedat Yetener, Esragül Akinci, Aylin Colpan, Ayse Erbay.   

Abstract

41 Brucella strains isolated from blood and cerebrospinal fluid cultures were identified to species level and biotypes detected. All of the isolates were Brucella melitensis: 2 strains of B. melitensis biotype-1 and 39 strains of B. melitensis biotype-3. In vitro activities of these strains were detected by the E test method. According to the 90% minimal inhibitory concentration (MIC90) values, the most active agent was doxycycline (MIC90 0.064 microg/ml), followed by ciprofloxacin (MIC90 0.25 microg/ml), trimethoprim-sulfamethoxazole and ceftriaxone (MIC90 0.38 microg/ml). Rifampin exhibited the highest MIC90 value (0.75 microg/ml).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875523     DOI: 10.1080/00365540310008348

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  17 in total

1.  Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates.

Authors:  Jay E Gee; Barun K De; Paul N Levett; Anne M Whitney; Ryan T Novak; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study.

Authors:  Hakan Erdem; Aysegül Ulu-Kilic; Selim Kilic; Mustafa Karahocagil; Ghaydaa Shehata; Necla Eren-Tulek; Funda Yetkin; Mustafa Kemal Celen; Nurgul Ceran; Hanefi Cem Gul; Gurkan Mert; Suda Tekin-Koruk; Murat Dizbay; Ayse Seza Inal; Saygin Nayman-Alpat; Mile Bosilkovski; Dilara Inan; Nese Saltoglu; Laila Abdel-Baky; Maria Teresa Adeva-Bartolome; Bahadir Ceylan; Suzan Sacar; Vedat Turhan; Emel Yilmaz; Nazif Elaldi; Zeliha Kocak-Tufan; Kenan Ugurlu; Basak Dokuzoguz; Hava Yilmaz; Sibel Gundes; Rahmet Guner; Nail Ozgunes; Asim Ulcay; Serhat Unal; Saim Dayan; Levent Gorenek; Ahmet Karakas; Yesim Tasova; Gaye Usluer; Yasar Bayindir; Behice Kurtaran; Oguz Resat Sipahi; Hakan Leblebicioglu
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 3.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  Multiple-locus variable-number tandem-repeat analysis genotyping of human Brucella isolates from Turkey.

Authors:  Selçuk Kiliç; Ivan N Ivanov; Riza Durmaz; Mehmet Refik Bayraktar; Ergin Ayaslioglu; M Hamidullah Uyanik; Hikmet Aliskan; Ekrem Yasar; Gülçin Bayramoglu; Ahmet Arslantürk; Gilles Vergnaud; Todor V Kantardjiev
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

5.  Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.

Authors:  Cinzia Marianelli; Caterina Graziani; Carmela Santangelo; Maria Teresa Xibilia; Alida Imbriani; Rosa Amato; Domenico Neri; Mario Cuccia; Sebastiano Rinnone; Vincenzo Di Marco; Franco Ciuchini
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

6.  Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.

Authors:  Yasemin Bayram; Hanifi Korkoca; Cenk Aypak; Mehmet Parlak; Aytekin Cikman; Selcuk Kilic; Mustafa Berktas
Journal:  Int J Med Sci       Date:  2011-03-03       Impact factor: 3.738

7.  In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

Authors:  Aun Turkmani; Alexandros Ioannidis; Athanasia Christidou; Anna Psaroulaki; Feidias Loukaides; Yiannis Tselentis
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-10-02       Impact factor: 3.944

8.  In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.

Authors:  Mohamed Abdel-Maksoud; Brent House; Momtaz Wasfy; Bassem Abdel-Rahman; Guillermo Pimentel; Gehan Roushdy; Erica Dueger
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-08-28       Impact factor: 3.944

9.  Efficacy evaluation of some antibiotics against syrian brucella spp isolates, in vitro.

Authors:  Mazen Safi; Ayman Al-Mariri
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.

Authors:  Esra Gültekin; Muhammet Hamidullah Uyanık; Ayşe Albayrak; Selçuk Kılıç
Journal:  Eur J Med Res       Date:  2021-06-16       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.